IRIS
CICERI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 23.587
EU - Europa 23.264
NA - Nord America 15.959
SA - Sud America 5.994
AF - Africa 512
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 69.380
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.128
RU - Federazione Russa 13.232
SG - Singapore 9.083
CN - Cina 6.599
BR - Brasile 4.899
IT - Italia 3.106
HK - Hong Kong 2.914
SE - Svezia 2.293
VN - Vietnam 2.273
FR - Francia 1.164
DE - Germania 860
BD - Bangladesh 739
GB - Regno Unito 589
IN - India 479
AR - Argentina 429
CA - Canada 384
FI - Finlandia 330
NL - Olanda 319
RO - Romania 282
AT - Austria 255
MX - Messico 252
JP - Giappone 225
EC - Ecuador 198
ID - Indonesia 187
ZA - Sudafrica 187
TR - Turchia 173
PL - Polonia 172
IQ - Iraq 166
ES - Italia 160
IE - Irlanda 143
CO - Colombia 110
PY - Paraguay 100
PK - Pakistan 89
CL - Cile 77
VE - Venezuela 75
UA - Ucraina 72
SA - Arabia Saudita 71
MA - Marocco 66
UZ - Uzbekistan 62
LT - Lituania 61
MY - Malesia 58
EG - Egitto 55
AE - Emirati Arabi Uniti 51
PH - Filippine 51
AU - Australia 47
DZ - Algeria 47
TN - Tunisia 47
UY - Uruguay 44
PE - Perù 41
IL - Israele 36
IR - Iran 35
NP - Nepal 35
JM - Giamaica 33
KE - Kenya 32
BE - Belgio 31
JO - Giordania 31
KR - Corea 31
AZ - Azerbaigian 26
DO - Repubblica Dominicana 26
KZ - Kazakistan 25
CR - Costa Rica 24
CH - Svizzera 23
LB - Libano 21
TT - Trinidad e Tobago 18
AL - Albania 17
ET - Etiopia 17
TH - Thailandia 17
CZ - Repubblica Ceca 16
SV - El Salvador 16
BY - Bielorussia 15
MD - Moldavia 15
PA - Panama 15
PT - Portogallo 15
TW - Taiwan 15
BO - Bolivia 14
HN - Honduras 14
DK - Danimarca 12
GT - Guatemala 12
NI - Nicaragua 12
OM - Oman 11
SY - Repubblica araba siriana 11
BG - Bulgaria 10
GR - Grecia 10
PS - Palestinian Territory 10
BA - Bosnia-Erzegovina 9
BH - Bahrain 9
CI - Costa d'Avorio 9
KW - Kuwait 9
HR - Croazia 8
HU - Ungheria 8
NG - Nigeria 8
NZ - Nuova Zelanda 8
AO - Angola 7
BW - Botswana 7
CY - Cipro 7
NO - Norvegia 7
RS - Serbia 7
SN - Senegal 7
BB - Barbados 6
GE - Georgia 6
Totale 69.267
Salva come PNG Salva come JPEG
Città #
Singapore 4.005
Moscow 2.898
Hong Kong 2.872
San Jose 2.239
Ashburn 2.215
Dallas 2.023
Shanghai 1.330
Hefei 1.099
Lauterbourg 947
Lawrence 812
Princeton 811
Ho Chi Minh City 808
Milan 764
New York 758
Beijing 746
Hanoi 485
São Paulo 464
Los Angeles 424
Santa Clara 283
Nuremberg 252
Rome 250
Boardman 233
Munich 176
Orem 166
Helsinki 163
Rio de Janeiro 157
Tokyo 150
Warsaw 142
Brooklyn 133
Dublin 132
London 131
Denver 123
Chennai 122
Guangzhou 122
Montreal 122
Vienna 120
Washington 111
Belo Horizonte 110
Johannesburg 108
Da Nang 106
Stockholm 101
Haiphong 98
Council Bluffs 97
Cesano Boscone 96
Manchester 94
Atlanta 93
Poplar 93
Mexico City 92
Lappeenranta 88
Frankfurt am Main 87
Chicago 86
Phoenix 84
Toronto 84
Curitiba 83
Brasília 82
Brescia 82
Seattle 82
Amsterdam 78
Ankara 76
Guayaquil 72
The Dalles 71
Turku 71
Campinas 69
Pune 69
Quito 69
Boston 65
Houston 63
Baghdad 62
Castelseprio 61
Bologna 59
Porto Alegre 59
Buffalo 58
Salvador 57
Hangzhou 56
Tashkent 56
Biên Hòa 53
Tianjin 53
Hải Dương 52
Naples 52
Turin 52
Mumbai 47
Shenzhen 47
Columbus 43
San Francisco 43
Dhaka 42
Guarulhos 42
Goiânia 41
Santo André 41
Buenos Aires 39
Jakarta 39
Montevideo 36
Thái Bình 36
Bergamo 35
Florence 35
Querétaro 35
Changsha 33
Monza 33
Ribeirão Preto 33
Genoa 32
Kuala Lumpur 32
Totale 32.831
Salva come PNG Salva come JPEG
Nome #
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy 389
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study 388
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 224
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 221
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 215
Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations 214
Use of HSV-TK transduced donor lymphocytes in the context of allogeneic bone marrow transplantation: A paradigm of current applications and limitations in gene therapy 212
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 206
Loss of mismatched HLA in leukemia after stem-cell transplantation 200
Validation of the “fitness criteria” for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL) 185
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 177
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 176
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 174
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 171
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 168
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 167
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 167
A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies 166
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 166
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 163
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 160
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 159
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation 159
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 159
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 158
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 156
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia 155
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 155
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 154
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 153
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 149
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 148
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 146
Biobanking for COVID-19 research 145
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 145
Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation 143
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 143
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 142
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 141
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 139
A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells 139
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy 139
Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients 138
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 138
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 137
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 137
Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia 136
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 135
A novel genomic inversion in Wiskott-Aldrich-associated autoinflammation 134
Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus 133
CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease 132
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 132
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 130
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients 130
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub 129
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 128
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 127
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 127
QTc interval prolongation, inflammation, and mortality in patients with COVID-19 126
Physical and psychological sequelae at three months after acute illness in COVID-19 survivors 126
Long-term lineage commitment in haematopoietic stem cell gene therapy 125
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 125
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party 125
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 125
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia 124
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 124
A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study 124
CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature 123
A T cell epitope encoded by a subset HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation 123
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study 123
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies 122
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 121
One-year mental health outcomes in a cohort of COVID-19 survivors 121
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation 120
A phase II multicenter trial of HSV-TK engineered donor lymphocytes after haplo-identical HSCT: Early immune reconstitution and abrogation of GvHD 120
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 120
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 120
Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide 119
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series 119
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 118
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation 118
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 118
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease 117
Results from the HLA COVID-Italia study: An unexpected correlation between HLA-DP antigen load and COVID-19 severity 116
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 116
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias 116
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 116
CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade 116
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study 116
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 115
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT 115
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 115
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study 114
Bone marrow as source of hematopoietic stem cells for human gene therapy of beta thalassemia 114
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 114
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain 114
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience 113
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 113
A dual role for genetically modified lymphocytes in cancer immunotherapy 113
COVID-19 mortality rate in nine high-income metropolitan regions 113
Totale 14.554
Salva come PNG Salva come JPEG
Categoria #
all - tutte 440.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 440.838
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/2022751 11 2 8 240 55 36 65 102 57 90 27 58
2022/20234.925 1.762 862 248 92 190 567 209 334 392 76 113 80
2023/20243.456 201 226 396 356 327 626 192 273 29 137 179 514
2024/202515.337 1.666 466 332 471 479 1.263 2.157 1.450 2.454 2.073 1.176 1.350
2025/202645.894 3.275 3.470 3.226 6.716 3.357 1.293 4.345 3.161 11.765 2.324 1.669 1.293
Totale 70.892